Immune dysregulation, apoptosis impairment, and enhanced seroreactivity to Anisakis simplex in Crohn's disease: interplay of IL-7/IL-7R signalling and CD132 deficiency

BACKGROUND: In previous studies, we identified a deficiency of gammadelta T cells and an increased prevalence of anti-Anisakis simplex antibodies in patients with Crohn's disease (CD). Additionally, decreased gene expression of the interleukin 2 (IL-2) receptor gamma subunit (CD132) was observe...

Descripción completa

Detalles Bibliográficos
Autores: Cuellar, Carmen, Hurtado-Marcos, Carolina, Valdivieso, Elizabeth, Vaccaro, Lucianna, Gonzalez-Fernandez, Juan, Jimenez, Ana Isabel, Perez-Griera, Jaume, Benlloch, Salvador, Amoros, Cirilo, Gil-Borras, Rafael, Sorando-Serra, Rosa, Cano-Cano, Maria Jose, Andreu-Ballester, Juan Carlos
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2026
País:España
Institución:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Repositorio:r-FISABIO. Repositorio Institucional de Producción Científica
OAI Identifier:oai:dnet:r-fisabio___::82699f240567edbf784c26e1d0c4b352
Acceso en línea:https://fisabio.portalinvestigacion.com/publicaciones/21116
Access Level:acceso abierto
Palabra clave:Crohn's disease
anti-Anisakis simplex antibodies
IL-7 gene expression
IL-2 receptor subunit gamma (CD 132)
caspase-3
Descripción
Sumario:BACKGROUND: In previous studies, we identified a deficiency of gammadelta T cells and an increased prevalence of anti-Anisakis simplex antibodies in patients with Crohn's disease (CD). Additionally, decreased gene expression of the interleukin 2 (IL-2) receptor gamma subunit (CD132) was observed in tissues from CD patients. OBJECTIVE: To analyse the gene expression of IL-7 and its receptors in tissues from CD patients and to explore its relationship with anti-A. simplex antibodies. METHODS: 52 patients diagnosed with CD were compared with a control group of 52 healthy individuals. Peripheral blood samples were analysed to assess levels of anti-A. simplex antibodies and IL-7. In addition, intestinal tissue samples from 20 subjects in each group were examined to evaluate IL-7 gene expression, IL-7 protein levels, the IL-2 receptor gamma subunit (CD132), the IL-7 receptor alpha subunit (CD127), and caspase-3 expression. FINDINGS: Anti-A. simplex antibody levels were elevated in patients with CD. Caspase-3 expression was significantly reduced in the tissues of CD patients with anti-A. simplex IgA, and this reduction extended to IgG and IgE in healthy individuals. A negative correlation was observed between caspase-3 levels and serum anti-A. simplex IgA, as well as IL-7 levels in the tissues of CD patients. In healthy subjects, tissue IL-7 levels were lower in those positive for anti-A. simplex IgA, while serum IL-7 levels were higher in individuals positive for anti-A. simplex IgG. MAIN CONCLUSIONS: This study revealed the interplay between IL-7 signalling, gammadelta T cell deficiency, and immune responses to A. simplex in CD. Our findings underscored a cause-effect relationship between CD132 deficiency, gammadelta T cell depletion, and defective mucosal immunity, which may drive both CD inflammation and susceptibility to parasitic infections like A. simplex.